Evaluation of the hemostatic effect of desmopressin nasal spray in rhinoplasty
Phase 3
Recruiting
- Conditions
- Rhinoplasty.
- Registration Number
- IRCT20210424051060N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Age over 18 years
Hemoglobin above 10
Patients without coagulation disorders
Exclusion Criteria
Coagulant disorder
A condition associated with clot such as CVA, thrombosis
Drug sensitivity to desmopressin
Hypertension
Taking drugs that affect coagulation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding. Timepoint: In the 30th and 60th minutes after the start of surgery. Method of measurement: According to Beozaart criteria.
- Secondary Outcome Measures
Name Time Method Surgeon satisfaction. Timepoint: At the end of surgery. Method of measurement: According to the Likert scale.;Length of surgery. Timepoint: End of surgery. Method of measurement: Surgery time based on minutes.